Clinical Trial

Improving Medication Management in World Trade Center Responders

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 15, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
By 2030, the majority of World Trade Center (WTC) rescue and recovery workers (responders) will be aged 65 and over and at risk for aging-related conditions and consequences including the concurrent use of five or more medications (i.e., polypharmacy). The purpose of this research study is to investigate an educational approach targeting polypharmacy through de-prescribing unnecessary and burdensome medications via the support of informed discussions between WTC responders and their prescribing physicians.
Trial Details
NCT Number NCT07022990
Lead Sponsor Icahn School of Medicine at Mount Sinai
Conditions Polypharmacy
Enrollment 50 participants
Start Date 2025-04-08
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-06-15